Mark E. Duggan
Impact in
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Receptor Mechanisms and Signaling 11
- Chemical Synthesis and Analysis 7
-
- Cell Adhesion Molecules Research 13
- Co-authors
- George D. Hartman (29 shared papers)Michele Potashman (1 shared paper)Craig W. Lindsley (17 shared papers)Zhijian Zhao (5 shared papers)Joel R. Huff (5 shared papers)Stanley F. Barnett (4 shared papers)Hans E. Huber (4 shared papers)Deborah Defeo-Jones (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (19 papers)Journal of Medicinal Chemistry (13 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Neuropharmacology (2 papers)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Mark E. Duggan
50 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 112
- Immunology and Allergy 440
- Cellular and Molecular Neuroscience 751
- Organic Chemistry 849
- Molecular Biology 1.8k
- Hematology 271
Countries citing papers authored by Mark E. Duggan
This map shows the geographic impact of Mark E. Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Duggan more than expected).
Fields of papers citing papers by Mark E. Duggan
This network shows the impact of papers produced by Mark E. Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Duggan. The network helps show where Mark E. Duggan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Duggan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 434 | |
| 2 | 2009 | 294 | |
| 3 | 1992 | 257 | |
| 4 | 2005 | 244 | |
| 5 | 1994 | 155 | |
| 6 | 2005 | 151 | |
| 7 | 2004 | 149 | |
| 8 | 2004 | 144 | |
| 9 | 1988 | 137 | |
| 10 | 2005 | 129 | |
| 11 | 2015 | 81 | |
| 12 | 2000 | 72 | |
| 13 | 2004 | 64 | |
| 14 | 1995 | 60 | |
| 15 | 2006 | 60 | |
| 16 | 2000 | 57 | |
| 17 | 2000 | 48 | |
| 18 | 2002 | 45 | |
| 19 | 2002 | 40 | |
| 20 | 2017 | 40 |
About Mark E. Duggan
Mark E. Duggan is a scholar working on Molecular Biology, Immunology and Allergy, Oncology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 50 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (13 papers), Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (9 papers), Platelet Disorders and Treatments (8 papers), Chemical Synthesis and Analysis (7 papers), Inflammatory mediators and NSAID effects (6 papers), Bone health and treatments (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Immunology and Allergy (440 citations), Cellular and Molecular Neuroscience (751 citations), Organic Chemistry (849 citations), Molecular Biology (1.8k citations) and Hematology (271 citations). Mark E. Duggan has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include George D. Hartman, Michele Potashman, Craig W. Lindsley, Zhijian Zhao, Joel R. Huff, Stanley F. Barnett, Hans E. Huber, Deborah Defeo-Jones, Raymond E. Jones and R. Robinson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Neuropharmacology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.